Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | KCNJ2 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → KCNJ2 |
| (<<) ATF4 → KCNJ2 |
| (<<) CDK7 → KCNJ2 |
| (<<) CLPP → KCNJ2 |
| (<<) ELOVL1 → KCNJ2 |
| (<<) FOXB1 → KCNJ2 |
| (<<) GNB2 → KCNJ2 |
| (<<) HRAS → KCNJ2 |
| (<<) MAP2K3 → KCNJ2 |
| (<<) MAP3K7 → KCNJ2 |
| (<<) SLC26A1 → KCNJ2 |
| (<<) STK4 → KCNJ2 |
| (<<) TEX10 → KCNJ2 |
| (<<) UBE2D2 → KCNJ2 |
| (<<) VPS28 → KCNJ2 |
| Downstream (Children) |
|---|
| KCNJ2 → BAD (>>) |
| KCNJ2 → CRLF3 (>>) |
| KCNJ2 → CYP4F2 (>>) |
| KCNJ2 → DUSP10 (>>) |
| KCNJ2 → EP300 (>>) |
| KCNJ2 → EPHA2 (>>) |
| KCNJ2 → GNRH2 (>>) |
| KCNJ2 → GRHPR (>>) |
| KCNJ2 → HPCAL1 (>>) |
| KCNJ2 → LARP6 (>>) |
| KCNJ2 → LBX1 (>>) |
| KCNJ2 → LRP6 (>>) |
| KCNJ2 → MAL (>>) |
| KCNJ2 → MN1 (>>) |
| KCNJ2 → MPP1 (>>) |
| KCNJ2 → MYL5 (>>) |
| KCNJ2 → OSBPL8 (>>) |
| KCNJ2 → PHOX2A (>>) |
| KCNJ2 → POU3F3 (>>) |
| KCNJ2 → PPP2R5C (>>) |
| KCNJ2 → PTPRE (>>) |
| KCNJ2 → RCAN1 (>>) |
| KCNJ2 → RHOD (>>) |
| KCNJ2 → RPS6KA5 (>>) |
| KCNJ2 → RPS6KB1 (>>) |
| KCNJ2 → SMURF1 (>>) |
| KCNJ2 → STK16 (>>) |
| KCNJ2 → TAF9 (>>) |
| KCNJ2 → TARS (>>) |
| KCNJ2 → TMEM158 (>>) |
| KCNJ2 → TNF (>>) |
| KCNJ2 → TNFRSF1A (>>) |
